143 related articles for article (PubMed ID: 16317296)
1. Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study.
Dobelbower MC; Russo SM; Raisch KP; Seay LL; Clemons LK; Suter S; Posey J; Bonner JA
Anticancer Drugs; 2006 Jan; 17(1):95-102. PubMed ID: 16317296
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
3. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
4. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy of esophageal carcinoma.
Poplin EA; Khanuja PS; Kraut MJ; Herskovic AM; Lattin PB; Cummings G; Gaspar LE; Kinzie JL; Steiger Z; Vaitkevicius VK
Cancer; 1994 Aug; 74(4):1217-24. PubMed ID: 8055441
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.
Li G; Hu W; Wang J; Deng X; Zhang P; Zhang X; Xie C; Wu S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1407-12. PubMed ID: 20350790
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus.
Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH
Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities.
Messersmith WA; Laheru DA; Senzer NN; Donehower RC; Grouleff P; Rogers T; Kelley SK; Ramies DA; Lum BL; Hidalgo M
Clin Cancer Res; 2004 Oct; 10(19):6522-7. PubMed ID: 15475439
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.
Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg R; Benson A
J Clin Oncol; 1996 Jan; 14(1):149-55. PubMed ID: 8558190
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of escalating-dose cisplatin with 5-fluorouracil and concurrent radiotherapy in Chinese patients with esophageal cancer.
Lin Q; Gao XS; Qiao XY; Zhou ZG; Zhang P; Chen K; Zhao YN; Asaumi J
Acta Med Okayama; 2008 Feb; 62(1):37-44. PubMed ID: 18323870
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study.
Jeremic B; Shibamoto Y; Acimovic L; Matovic Z; Milicic B; Milisavljevic S; Nikolic N
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1061-6. PubMed ID: 9539560
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).
Higuchi K; Koizumi W; Tanabe S; Sasaki T; Katada C; Ishiyama H; Hayakawa K
Radiother Oncol; 2008 Jun; 87(3):398-404. PubMed ID: 18405987
[TBL] [Abstract][Full Text] [Related]
19. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.
Poplin EA; Jacobson J; Herskovic A; Panella TJ; Valdivieso M; Hutchins LF; Macdonald JS
Cancer; 1996 Nov; 78(9):1851-6. PubMed ID: 8909302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
